Abstract: Disclosed herein are systems and methods for providing a portable magnetic field therapy system for inducing an effect of a chemical or biochemical agent to a mammalian subject, such as for the treatment of diseases and adverse health conditions.

Abstract: A system for delivery of ultra-low radio frequency energy to an individual to assist the individual to remain, or become, alert, awake, or focused includes at least one delivery coil and a delivery device that includes at least one memory; at least one data file configured for producing signals derived from measurements of at least one molecule; and at least one processor coupled to the at least one memory and the at least one delivery coil. The at least one processor is configured to perform actions that include directing generation of the signals using the at least one data file and directing delivery of the signals to the at least one delivery coil to produce the ultra-low radio frequency energy.

Abstract: A method for identifying patterns and associated functions or structural features in molecules includes measuring an electromagnetic field of a target molecule in at least two dimensions using an array of magnetic field sensor devices; identifying at least one pattern in the measured electromagnetic fields of the target molecule and the other molecules; and associating the at least one pattern with at least one function or structural feature of the target molecule.

Abstract: Disclosed herein are systems and methods for providing a portable magnetic field therapy system for inducing an effect of a chemical or biochemical agent to a mammalian subject, such as for the treatment of diseases and adverse health conditions.

Abstract: A measurement system includes a container configured to contain a solvated target molecule and at least one magnetoresistive (MR) sensor device including at least one MR sensor disposed near the container and configured to measure a magnetic field generated by the solvated target molecule, each of the at least one MR sensor including a pin layer having a pinned direction of magnetization, a free layer having a direction of magnetization that varies with an applied magnetic field, and a non-conductive layer separating the pin layer and the free layer.

Abstract: A measurement system includes a container configured to contain a solvated target molecule and at least one magnetoresistive (MR) sensor device including at least one MR sensor disposed near the container and configured to measure a magnetic field generated by the solvated target molecule, each of the at least one MR sensor including a pin layer having a pinned direction of magnetization, a free layer having a direction of magnetization that varies with an applied magnetic field, and a non-conductive layer separating the pin layer and the free layer.

Abstract: A system for delivery of ultra-low radio frequency energy to an individual to assist the individual to remain, or become, alert, awake, or focused includes at least one delivery coil and a delivery device that includes at least one memory; at least one data file configured for producing signals derived from measurements of at least one molecule; and at least one processor coupled to the at least one memory and the at least one delivery coil. The at least one processor is configured to perform actions that include directing generation of the signals using the at least one data file and directing delivery of the signals to the at least one delivery coil to produce the ultra-low radio frequency energy.

Abstract: Disclosed herein are systems and methods for providing a portable magnetic field therapy system for inducing an effect of a chemical or biochemical agent to a mammalian subject, such as for the treatment of diseases and adverse health conditions.

Abstract: An incubator system includes an incubator unit including incubator chamber defined by chamber walls formed of a non-magnetic material; a control unit physically separated from the incubator unit and including operational controls for operation of the incubator system; and at least one duct coupling the incubator unit to the control unit, wherein the incubator system is configured so that the incubator chamber experiences a magnetic field variation of no more than 100 nT arising from the incubator system during incubation operation of the incubation system.

Abstract: A therapy delivery system includes a near field magnetic induction (NFMI) transceiver device configured to be worn or otherwise disposed on a patient, the NFMI transceiver device including a NFMI transceiver; and a therapy delivery device including a NFMI receiver configured to receive signals from the NFMI transceiver device and a therapy delivery circuit configured to deliver a therapeutic magnetic signal, based, at least in part, on the received signals from the NFMI transceiver device, to the patient when the patient wears the therapy delivery device or has the therapy delivery device disposed on skin of the patient or has the therapy delivery device implanted.

Abstract: Disclosed herein are systems and methods for providing a portable magnetic field therapy system for treatment of diseases and adverse health conditions, such as cancer.

Abstract: Disclosed herein are systems and methods for providing a portable magnetic field therapy system for treatment of diseases and adverse health conditions, such as cancer.

Abstract: Disclosed herein are systems and methods for providing a portable magnetic field therapy system for treatment of diseases and adverse health conditions, such as cancer.

Abstract: A method and apparatus for producing an effect of a chemical or biochemical agent on a system responsive to such agent, are disclosed. In practicing the method, a plurality of low-frequency time-domain signals of the agent are generated, each at a different at a different noise level within a selected noise level range. The signals are analyzed by producing spectral plots of the time-domain signals, and identifying an optimized agent-specific time-domain signal based on information in the spectral plots. A chemical or biological system responsive to the agent is exposed to the optimized time-domain signal by placing the system within the magnetic field of an electromagnetic transducer, and applying the signal to the transducer at a signal amplitude and for a period sufficient to produce in the system an agent-specific effect on the system.

Abstract: Disclosed herein are systems and methods for providing a portable magnetic field therapy system for treatment of diseases and adverse health conditions, such as cancer.

Abstract: A method and apparatus for producing an effect of a chemical or biochemical agent on a system responsive to such agent, are disclosed. In practicing the method, a plurality of low-frequency time-domain signals of the agent are generated, each at a different at a different noise level within a selected noise level range. The signals are analyzed by producing spectral plots of the time-domain signals, and identifying an optimized agent-specific time-domain signal based on information in the spectral plots. A chemical or biological system responsive to the agent is exposed to the optimized time-domain signal by placing the system within the magnetic field of an electromagnetic transducer, and applying the signal to the transducer at a signal amplitude and for a period sufficient to produce in the system an agent-specific effect on the system.

Abstract: A method of forming an aqueous composition effective to produce an agent-specific effect on an agent-responsive chemical or biological system, when the composition is added to the system, is disclosed. The composition is formed by exposing an aqueous medium to a low-frequency, time-domain signal derived from the agent, until the aqueous medium acquires a detectable agent activity. Exemplary compositions are formed by exposure to a paclitaxel signal or a signal derived from a therapeutic oligonucleotide, such as GAPDH antisense RNA and PCSK9 antisense RNA. Also disclosed are methods for confirming the activity of the composition, and for preparing and testing the activity of the compositions.

Abstract: Method and apparatus for generating and selecting low-frequency time-domain signals capable of transducing a mammalian system, to produce an agent-specific effect on the system, are disclosed. Low-frequency time-domain signals are generated in the presence of an injected magnetic stimulus, and the resulting signals are selected by a scoring algorithm, and optionally, by testing each signal identified by the scoring algorithm for its ability to produce an agent-specific response in a in vitro system containing components that are responsive to the agent. The selected signals are used to transduce the mammalian system by applying the signals to an electromagnetic transduction coil that holds the sample.

Abstract: A method and apparatus for producing an effect of a chemical or biochemical agent on a system responsive to such agent, are disclosed. In practicing the method, a plurality of low-frequency time-domain signals of the agent are generated, each at a different at a different noise level within a selected noise level range. The signals are analyzed by producing spectral plots of the time-domain signals, and identifying an optimized agent-specific time-domain signal based on information in the spectral plots. A chemical or biological system responsive to the agent is exposed to the optimized time-domain signal by placing the system within the magnetic field of an electromagnetic transducer, and applying the signal to the transducer at a signal amplitude and for a period sufficient to produce in the system an agent-specific effect on the system.

Abstract: A method and apparatus for interrogating a sample that exhibits molecular rotation are disclosed. In practicing the method, the sample is placed in a container having both magnetic and electromagnetic shielding, and Gaussian noise is injected into the sample. An electromagnetic time-domain signal composed of sample source radiation superimposed on the injected Guassian noise is detected, and this signal is cross-correlated with a second time-domain signal produced by the same or similar sample, to produce a cross-correlated signal with frequency domain components. The latter is plotted in the frequency domain by a fast Fourier transform to produce a frequency domain spectrum in a frequency range within DC to 50 KHz. From this spectrum, one or more low-frequency signal components that are characteristic of the sample being interrogated are identified.